An intronic PICALM polymorphism, rs588076, is associated with allelic expression of a PICALM isoform

详细信息    查看全文

• 作者：Ishita Parikh ; Christopher Medway ; Steven Younkin…
• 关键词：PICALM ; Alzheimer’s disease ; Next ; generation sequencing ; Allelic expression imbalance ; Single nucleotide polymorphism
• 刊名：Molecular Neurodegeneration
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：9
• 期：1
• 全文大小：901 KB
• 参考文献：1. Baig, S, Joseph, SA, Tayler, H, Abraham, R, Owen, MJ, Williams, J, Kehoe, PG, Love, S (2010) Distribution and expression of picalm in Alzheimer disease. J Neuropathol Exp Neurol 69: pp. 1071-1077 CrossRef
  2. Parikh, I, Fardo, DW, Estus, S (2014) Genetics of PICALM expression and Alzheimer’s disease. PLoS One 9: pp. e91242 CrossRef
  3. Xiao, Q, Gil, SC, Yan, P, Wang, Y, Han, S, Gonzales, E, Perez, R, Cirrito, JR, Lee, JM (2012) Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis. J Biol Chem 287: pp. 21279-21289 CrossRef
  4. D’Angelo, F, Vignaud, H, Di Martino, J, Salin, B, Devin, A, Cullin, C, Marchal, C (2013) A yeast model for amyloid-beta aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity. Dis Model Mech 6: pp. 206-216 CrossRef
  5. Kanatsu, K, Morohashi, Y, Suzuki, M, Kuroda, H, Watanabe, T, Tomita, T, Iwatsubo, T (2014) Decreased CALM expression reduces Abeta42 to total Abeta ratio through clathrin-mediated endocytosis of gamma-secretase. Nat Commun 5: pp. 3386 CrossRef
  6. Harold, D, Abraham, R, Hollingworth, P, Sims, R, Gerrish, A, Hamshere, ML, Pahwa, JS, Moskvina, V, Dowzell, K, Williams, A, Jones, N, Thomas, C, Stretton, A, Morgan, AR, Lovestone, S, Powell, J, Proitsi, P, Lupton, MK, Brayne, C, Rubinsztein, DC, Gill, M, Lawlor, B, Lynch, A, Morgan, K, Brown, KS, Passmore, PA, Craig, D, McGuinness, B, Todd, S, Holmes, C (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 41: pp. 1088-1093 CrossRef
  7. Jun, G, Naj, AC, Beecham, GW, Wang, LS, Buros, J, Gallins, PJ, Buxbaum, JD, Ertekin-Taner, N, Fallin, MD, Friedland, R, Inzelberg, R, Kramer, P, Rogaeva, E, St George-Hyslop, P, Cantwell, LB, Dombroski, BA, Saykin, AJ, Reiman, EM, Bennett, DA, Morris, JC, Lunetta, KL, Martin, ER, Montine, TJ, Goate, AM, Blacker, D, Tsuang, DW, Beekly, D, Cupples, LA, Hakonarson, H, Kukull, W (2010) Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 67: pp. 1473-1484 CrossRef
  8. Lambert, JC, Heath, S, Even, G, Campion, D, Sleegers, K, Hiltunen, M, Combarros, O, Zelenika, D, Bullido, MJ, Tavernier, B, Letenneur, L, Bettens, K, Berr, C, Pasquier, F, Fievet, N, Barberger-Gateau, P, Engelborghs, S, De Deyn, P, Mateo, I, Franck, A, Helisalmi, S, Porcellini, E, Hanon, O, de Pancorbo, MM, Lendon, C, Dufouil, C, Jaillard, C, Leveillard, T, Alvarez, V, Bosco, P (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41: pp. 1094-1099 CrossRef
  9. Seshadri, S, Fitzpatrick, AL, Ikram, MA, DeStefano, AL, Gudnason, V, Boada, M, Bis, JC, Smith, AV, Carassquillo, MM, Lambert, JC, Harold, D, Schrijvers, EM, Ramirez-Lorca, R, Debette, S, Longstreth, WT, Janssens, AC, Pankratz, VS, Dartigues, JF, Hollingworth, P, Aspelund, T, Hernandez, I, Beiser, A, Kuller, LH, Koudstaal, PJ, Dickson, DW, Tzourio, C, Abraham, R, Antunez, C, Du, Y, Rotter, JI (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303: pp. 1832-1840 CrossRef
  10. Pedraza, O, Allen, M, Jennette, K, Carrasquillo, M, Crook, J, Serie, D, Pankratz, VS, Palusak, R, Nguyen, T, Malphrus, K, Ma, L, Bisceglio, G, Roberts, RO, Lucas, JA, Ivnik, RJ, Smith, GE, Graff-Radford, NR, Petersen, RC, Younkin, SG, Ertekin-Taner, N (2014) Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects. Alzheimers Dement 10: pp. 205-213 CrossRef
  11. Liu, G, Zhang, S, Cai, Z, Ma, G, Zhang, L, Jiang, Y, Feng, R, Liao, M, Chen, Z, Zhao, B, Li, K (
• 刊物主题：Neurosciences; Neurology; Molecular Medicine;
• 出版者：BioMed Central
• ISSN：1750-1326

文摘

Background Although genome wide studies have associated single nucleotide polymorphisms (SNP)s near PICALM with Alzheimer’s disease (AD), the mechanism underlying this association is unclear. PICALM is involved in clathrin-mediated endocytosis and modulates A? clearance in vitro. Comparing allelic expression provides the means to detect cis-acting regulatory polymorphisms. Thus, we evaluated whether PICALM showed allele expression imbalance (AEI) and whether this imbalance was associated with the AD-associated polymorphism, rs3851179. Results We measured PICALM allelic expression in 42 human brain samples by using next-generation sequencing. Overall, PICALM demonstrated equal allelic expression with no detectable influence by rs3851179. A single sample demonstrated robust global PICALM allelic expression imbalance (AEI), i.e., each of the measured isoforms showed AEI. Moreover, the PICALM isoform lacking exons 18 and 19 (D18-19 PICALM) showed significant AEI in a subset of individuals. Sequencing these individuals and subsequent genotyping revealed that rs588076, located in PICALM intron 17, was robustly associated with this imbalance in D18-19 PICALM allelic expression (p--.54 x 10-5). This polymorphism has been associated previously with systolic blood pressure response to calcium channel blocking agents. To evaluate whether this polymorphism was associated with AD, we genotyped 3269 individuals and found that rs588076 was modestly associated with AD. However, when both the primary AD SNP rs3851179 was added to the logistic regression model, only rs3851179 was significantly associated with AD. Conclusions PICALM expression shows no evidence of AEI associated with rs3851179. Robust global AEI was detected in one sample, suggesting the existence of a rare SNP that strongly modulates PICALM expression. AEI was detected for the D18-19 PICALM isoform, and rs588076 was associated with this AEI pattern. Conditional on rs3851179, rs588076 was not associated with AD risk, suggesting that D18-19 PICALM is not critical in AD. In summary, this analysis of PICALM allelic expression provides novel insights into the genetics of PICALM expression and AD risk.